NICOTINAMIDE ADENINE DINUCLEOTIDE 1G & RETATRUTIDE : A UNITED KINGDOM UPDATE

The emerging interest in NAD+ supplementation, particularly at a substantial dosage of 1g , continues to rise within the UK healthcare community. At the same time , attention is firmly fixed on Retatrutide, a groundbreaking GLP-1 receptor agonist being viewed by many as a potential replacement to